Viewing Study NCT02796261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-02-21 @ 10:11 PM
Study NCT ID: NCT02796261
Status: UNKNOWN
Last Update Posted: 2022-01-21
First Post: 2016-06-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
Sponsor: Orbus Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anaplastic Astrocytoma View
None Recurrent Anaplastic Astrocytoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anaplastic Astrocytoma View
None Grade 3 Glioma View
None Glioma View
None Eflornithine View
None Brain Cancer View
None Brain Tumor View
None Neuro-oncology View
None Progressive Anaplastic Astrocytoma View
None Recurrent Anaplastic Astrocytoma View
None Progressive Glioma View
None Recurrent Glioma View
None Malignant Glioma View
None Progressive Brain Tumor View
None Recurrent Brain Tumor View